Sign up to get updates from us
Hear how Captor Therapeutics became a Swiss/Polish public biotech company run by a Scotsman –as told by 30-year healthcare industry veteran and Captor’s CEO, Dr. Tom Shepherd. That’s one great story – another is how Captor’s targeted protein degradation platform will stick it to the competition with their ligase library, and proprietary molecular glues and bifunctional degraders...
